Hunan Hansen Pharmaceutical Co Ltd (002412) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.51 Million ≈ $7.68 Million USD) by net assets (CN¥2.26 Billion ≈ $330.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hunan Hansen Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Hunan Hansen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LB Foster Company
NASDAQ:FSTR
|
-0.060x |
|
Issta Lines Ltd
TA:ISTA
|
0.034x |
|
Vishnu Chemicals Limited
NSE:VISHNU
|
0.085x |
|
Savita Oil Technologies Limited
NSE:SOTL
|
0.054x |
|
Evolus Inc
NASDAQ:EOLS
|
0.346x |
|
Aeluma, Inc
NASDAQ:ALMU
|
-0.006x |
|
Hangzhou Zhongya Machinery Co Ltd
SHE:300512
|
0.026x |
|
Zhejiang Dibay Electric Co Ltd
SHG:603320
|
0.023x |
Annual Cash Flow Conversion Efficiency for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Hunan Hansen Pharmaceutical Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.38 Billion ≈ $348.40 Million |
CN¥245.38 Million ≈ $35.91 Million |
0.103x | +73.63% |
| 2024-12-31 | CN¥2.20 Billion ≈ $322.42 Million |
CN¥130.78 Million ≈ $19.14 Million |
0.059x | -27.60% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.25 Million |
CN¥160.95 Million ≈ $23.55 Million |
0.082x | +7.99% |
| 2022-12-31 | CN¥1.89 Billion ≈ $277.17 Million |
CN¥143.81 Million ≈ $21.04 Million |
0.076x | -37.76% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.95 Million |
CN¥212.54 Million ≈ $31.10 Million |
0.122x | +19.95% |
| 2020-12-31 | CN¥1.59 Billion ≈ $233.36 Million |
CN¥162.19 Million ≈ $23.73 Million |
0.102x | -5.76% |
| 2019-12-31 | CN¥1.53 Billion ≈ $223.88 Million |
CN¥165.11 Million ≈ $24.16 Million |
0.108x | -32.36% |
| 2018-12-31 | CN¥1.36 Billion ≈ $199.50 Million |
CN¥217.52 Million ≈ $31.83 Million |
0.160x | +81.50% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.41 Million |
CN¥107.18 Million ≈ $15.68 Million |
0.088x | -31.35% |
| 2016-12-31 | CN¥1.26 Billion ≈ $184.16 Million |
CN¥161.16 Million ≈ $23.58 Million |
0.128x | +152.48% |
| 2015-12-31 | CN¥1.25 Billion ≈ $183.42 Million |
CN¥63.57 Million ≈ $9.30 Million |
0.051x | -31.23% |
| 2014-12-31 | CN¥1.15 Billion ≈ $168.75 Million |
CN¥85.05 Million ≈ $12.44 Million |
0.074x | +7.35% |
| 2013-12-31 | CN¥1.11 Billion ≈ $162.08 Million |
CN¥76.09 Million ≈ $11.13 Million |
0.069x | -33.85% |
| 2012-12-31 | CN¥965.11 Million ≈ $141.23 Million |
CN¥100.23 Million ≈ $14.67 Million |
0.104x | +70.44% |
| 2011-12-31 | CN¥883.65 Million ≈ $129.31 Million |
CN¥53.84 Million ≈ $7.88 Million |
0.061x | +157.83% |
| 2010-12-31 | CN¥898.82 Million ≈ $131.53 Million |
CN¥21.24 Million ≈ $3.11 Million |
0.024x | -89.66% |
| 2009-12-31 | CN¥179.51 Million ≈ $26.27 Million |
CN¥41.02 Million ≈ $6.00 Million |
0.228x | -12.30% |
| 2008-12-31 | CN¥130.26 Million ≈ $19.06 Million |
CN¥33.94 Million ≈ $4.97 Million |
0.261x | -39.43% |
| 2007-12-31 | CN¥87.77 Million ≈ $12.84 Million |
CN¥37.75 Million ≈ $5.52 Million |
0.430x | -- |
About Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syru… Read more